CancerGEMKB logo   CancerGEM KB (Cancer Genomic Evidence-based Medicine Knowledge Base) (version 1.0)
   An integrated, searchable knowledge base of cancer human genome epidemiology and genomic applications in cancer care and prevention .
line
 Last data upload: 17 Dec 2014. (Total 24325 articles)  

Cancer HuGE Literature Finder

Data collected since 2001

Home  |  About  |  Search Instructions |  FAQs 

Search  
 for
Search Criteria: All publications

Filtered By  

Articles 1 - 25 of 24325
Export Display on    of 974
1.
CCND1 gene polymorphic variants in patients with differentiated thyroid carcinoma. [Detail]
Oncology letters 2015 Jan 9 (1): 1.
Hryhorowicz S, Ziemnicka K, Kaczmarek-Ry? M, Hoppe-Go??biewska J, P?awski A, Skrzypczak-Zieli?ska M, Szkudlarek M, Go??b M, Budny B, Rucha?a M, S?omski R
2.
Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History-Based Testing. [Detail]
Journal of the National Cancer Institute 2015 Jan 107 (1): 1.
Manchanda R, Legood R, Burnell M, McGuire A, Raikou M, Loggenberg K, Wardle J, Sanderson S, Gessler S, Side L, Balogun N, Desai R, Kumar A, Dorkins H, Wallis Y, Chapman C, Taylor R, Jacobs C, Tomlinson I, Beller U, Menon U, Jacobs I
3.
Five COX-2 gene polymorphisms and risk of breast cancer: an updated meta-analysis based on 19 case-control studies. [Detail]
Medical oncology (Northwood, London, England) 2015 Jan 32 (1): 1.
Li Q, Liu L, Liu Y, Zhou H, Yang Z, Yuan K, Min W
4.
Interleukin-17A and interleukin-17F gene polymorphisms and hepatitis B virus-related hepatocellular carcinoma risk in a Chinese population. [Detail]
Medical oncology (Northwood, London, England) 2015 Jan 32 (1): 1.
Xi XE, Liu Y, Lu Y, Huang L, Qin X, Li S
5.
Polymorphism of DNA methyltransferase 3B -149C/T and cancer risk: a meta-analysis. [Detail]
Medical oncology (Northwood, London, England) 2015 Jan 32 (1): 1.
Zhu J, Du S, Zhang J, Wang Y, Wu Q, Ni J
6.
Population Testing for Cancer Predisposing BRCA1/BRCA2 Mutations in the Ashkenazi-Jewish Community: A Randomized Controlled Trial. [Detail]
Journal of the National Cancer Institute 2015 Jan 107 (1): 1.
Manchanda R, Loggenberg K, Sanderson S, Burnell M, Wardle J, Gessler S, Side L, Balogun N, Desai R, Kumar A, Dorkins H, Wallis Y, Chapman C, Taylor R, Jacobs C, Tomlinson I, McGuire A, Beller U, Menon U, Jacobs I
7.
Serine/threonine kinase 15 gene polymorphism and risk of digestive system cancers: A meta-analysis. [Detail]
Experimental and therapeutic medicine 2015 Jan 9 (1): 1.
Luo J, Yan R, Zou L
8.
[Studies on the association of single nucleotide polymorphisms of HLA-DP and DQ genes with the outcome of chronic hepatitis B virus infection]. [Detail]
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2014 Dec 31 (6): 6.
Su M, Zeng Y, Chen J, Jiang L, Chen T, Liu C, Yang B, Ou Q
9.
20 Years of lesson learning: how does the ret genetic screening test impact the clinical management of medullary thyroid cancer ? [Detail]
Clinical endocrinology 2014 Dec .
Romei C, Tacito A, Molinaro E, Agate L, Bottici V, Viola D, Matrone A, Biagini A, Casella F, Ciampi R, Materazzi G, Miccoli P, Torregrossa L, Ugolini C, Basolo F, Vitti P, Elisei R
10.
A Large-scale Cross-sectional Study of ALK Rearrangements and EGFR Mutations in Non-small-cell Lung Cancer in Chinese Han Population. [Detail]
Scientific reports 2014 4 .
Hong S, Fang W, Hu Z, Zhou T, Yan Y, Qin T, Tang Y, Ma Y, Zhao Y, Xue C, Huang Y, Zhao H, Zhang L
11.
A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancer. [Detail]
European journal of cancer (Oxford, England : 1990) 2014 Dec 50 (18): 18.
Hickish T, Cassidy J, Propper D, Chau I, Falk S, Ford H, Iveson T, Braun M, Potter V, Macpherson IR, Finnigan H, Lee C, Jones H, Harrison M
12.
An association between the -41657 C/T polymorphism of X-ray repair cross-complementing 2 (XRCC2) gene and ovarian cancer. [Detail]
Medical oncology (Northwood, London, England) 2014 Dec 31 (12): 12.
Michalska MM, Samulak D, Smolarz B
13.
Association between FOXP3 promoter polymorphisms and cancer risk: A meta-analysis. [Detail]
Oncology letters 2014 Dec 8 (6): 6.
Jiang LL, Ruan LW
14.
Association between polymorphism of GLI1 gene SNP rs2228226 and chronic lymphocytic leukemia in Chinese population. [Detail]
Medical oncology (Northwood, London, England) 2014 Dec 31 (12): 12.
Li YY, Tian T, Zhang R, Wang L, Xu J, Fan L, Li JY, Xu W
15.
Association between polymorphisms in tumor suppressor genes and oncogenes and risk of hepatocellular carcinoma: a case-control study in an HCC epidemic area within the Han Chinese population. [Detail]
Medical oncology (Northwood, London, England) 2014 Dec 31 (12): 12.
Su C, Lin Y, Niu J, Cai L
16.
Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes. [Detail]
Breast cancer research : BCR 2014 Dec 16 (6): 6.
Timms KM, Abkevich V, Hughes E, Neff C, Reid J, Morris B, Kalva S, Potter J, Tran TV, Chen J, Iliev D, Sangale Z, Tikishvili E, Perry M, Zharkikh A, Gutin A, Lanchbury JS
17.
Association of FoxP3 rs3761548 polymorphism with susceptibility to colorectal cancer in the Chinese population. [Detail]
Medical oncology (Northwood, London, England) 2014 Dec 31 (12): 12.
Chen L, Yu Q, Liu B, Zhu L
18.
Association of high CD4-positive T cell infiltration with mutations in HLA class II-regulatory genes in microsatellite-unstable colorectal cancer. [Detail]
Cancer immunology, immunotherapy : CII 2014 Dec .
Surmann EM, Voigt AY, Michel S, Bauer K, Reuschenbach M, Ferrone S, von Knebel Doeberitz M, Kloor M
19.
BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma. [Detail]
Blood 2014 Dec .
Correia C, Schneider PA, Dai H, Dogan A, Maurer MJ, Church AK, Novak AJ, Feldman AL, Wu X, Ding H, Meng XW, Cerhan JR, Slager SL, Macon WR, Habermann TM, Karp JE, Gore SD, Kay NE, Jelinek DF, Witzig TE, Nowakowski GS, Kaufmann SH
20.
BRAF mutation in papillary thyroid cancer: A cost-utility analysis of preoperative testing. [Detail]
Surgery 2014 Dec 156 (6): 6.
Lee WS, Palmer BJ, Garcia A, Chong VE, Liu TH
21.
Breast cancer sensitivity to neoadjuvant therapy in BRCA1 and CHEK2 mutation carriers and non-carriers. [Detail]
Breast cancer research and treatment 2014 Dec 148 (3): 3.
Pfeifer W, Sokolenko AP, Potapova ON, Bessonov AA, Ivantsov AO, Laptiev SA, Zaitseva OA, Yatsuk OS, Matsko DE, Semiglazova TY, Togo AV, Imyanitov EN
22.
Cruciferous vegetables and risk of colorectal neoplasms: a systematic review and meta-analysis. [Detail]
Nutrition and cancer 2014 66 (1): 1.
Tse G, Eslick GD
23.
Diet and lifestyle factors modify immune/inflammation response genes to alter breast cancer risk and prognosis: The Breast Cancer Health Disparities Study. [Detail]
Mutation research. Fundamental and molecular mechanisms of mutagenesis 2014 Dec 770 .
Slattery ML, Lundgreen A, Torres-Mejia G, Wolff RK, Hines L, Baumgartner K, John EM
24.
Differential Expression of GNAS and KRAS Mutations in Pancreatic Cysts. [Detail]
JOP : Journal of the pancreas 2014 15 (6): 6.
Lee LS, Doyle LA, Houghton J, Sah S, Bellizzi AM, Szafranska-Schwarzbach AE, Conner JR, Kadiyala V, Suleiman SL, Banks PA, Andruss BF, Conwell DL
25.
Functional polymorphisms of circadian negative feedback regulation genes are associated with clinical outcome in hepatocellular carcinoma patients receiving radical resection. [Detail]
Medical oncology (Northwood, London, England) 2014 Dec 31 (12): 12.
Zhang Z, Ma F, Zhou F, Chen Y, Wang X, Zhang H, Zhu Y, Bi J, Zhang Y
Export Display 25 on page   1 of  974
Articles 1 - 25 of 24325